Showing results (131-140 of 365) with videos related to

Sort By:
Pageof 37
Immunotargets and Therapy|December 24, 2024
Anti-GluK2 Encephalitis in an Asian Child: A Case Report and Literature ReviewShimeng Chen, Miriam Kessi, Fang He, et al.
Immunotargets and Therapy|December 16, 2024
Evolution of Hematobiochemical Profiles in Newly Diagnosed HIV Patients and HIV-TB Co-Infected Patients: Correlation with Immunological and Virological StatusNawaid Hussain Khan, Chaitenya Verma, Mirza Masroor Ali Beg, et al.
Immunotargets and Therapy|January 28, 2025
Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFBYuwei Bai, Xiaoyun Wang, Bei Wang
Immunotargets and Therapy|January 27, 2025
Increased Co-Expression of PD-L1 and CTLA-4 Predicts Poor Overall Survival in Patients with Acute Myeloid Leukemia Following Allogeneic Hematopoietic Stem Cell TransplantationCunte Chen, Kangjie Qiu, Jie Chen, et al.
Immunotargets and Therapy|January 7, 2025
Immune Checkpoint Inhibitor Combined with Antiangiogenic Agent Synergistically Improving the Treatment Efficacy for Solid TumorsYong Zhou, Zhengcheng Liu, Ao Yu, et al.
Immunotargets and Therapy|March 10, 2025
The Effects of M2 Macrophages-Derived Exosomes on Urethral Fibrosis and Stricture in Scar FormationXiang Ren, Zhixian Wang, Jing Wang, et al.
Immunotargets and Therapy|January 23, 2025
Targeting B and T Lymphocyte Attenuator Regulates Lupus Disease Development in NZB/W MiceLéa Gherardi, Lucie Aubergeon, Mélanie Sayah, et al.
Immunotargets and Therapy|January 30, 2025
PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching StudyZhaoqian He, Hua Chen, Chen Liang, et al.
Immunotargets and Therapy|August 26, 2024
Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective StudyWei Wang, Ruixia Li, Hui Li, et al.
Immunotargets and Therapy|October 31, 2024
Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor MicroenvironmentXiaoling Shang, Chenyue Zhang, Yuanyuan Lv, et al.
Pageof 37